April 26, 2016 / 11:02 AM / in a year

BRIEF-Prometic's drug efficacy further evidenced in Type 2 diabetic and metabolic syndrome clinical trial

April 26 (Reuters) - Prometic Life Sciences Inc

* Prometic's PBI-4050: efficacy further evidenced in type 2 diabetic and metabolic syndrome clinical trial

* New results from additional patients increase statistical and clinical evidence of efficacy

* Reduction of glycated hemoglobin (hba1c) reaches -0.9% (p=0.0004) in patients with hba1c  8% at baseline Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below